Table 2.
EBV treatment | (n = 30) | ||
Mean duration (range), min | 11 (5–25) | ||
Target lobe for EBV treatment, n (%) | Right upper lobe | 2 (7) | |
Right upper + middle lobe | 4 (13) | ||
Right lower lobe | 2 (7) | ||
Left upper lobe | 4 (13) | ||
Left lower lobe | 18 (60) | ||
Median EBV placed/patient, n (range) | 4 (2–6) | ||
EBV size 4.0 | 1 (0–3) | ||
EBV size 4.0-LP | 0 (0–2) | ||
EBV size 5.5 | 1 (0–3) | ||
EBV size 5.5-LP | 1 (1–3) | ||
Segments treated with 5.5-LP EBV, n | (n = 41) | ||
RBI | 3 | ||
RB2 | 2 | ||
RB3 | 1 | ||
RB4/5 | 1 | ||
RB6 | 3 | ||
RB9/10 | 2 | ||
LB1/2 | 1 | ||
LB3 | 4 | ||
LB6 | 14 | ||
LB8 | 4 | ||
LB9 | 3 | ||
LB10 | 2 | ||
LB8/9/10 | 1 |